Prospective Study of Betaferon in Adherence, Coping and Nurse Support in Patients of Chinese Origin With Multiple Sclerosis
Phase of Trial: Phase IV
Latest Information Update: 19 Sep 2016
At a glance
- Drugs Interferon beta-1b (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors Bayer
- 23 Oct 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 Sep 2013 Planned end date changed from 1 Jun 2015 to 1 Sep 2015 as reported by ClinicalTrials.gov.